A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Nature Genetics

• Publication date

  1992-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/NG0892-345PMID 1302033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Processing of the amyloid protein precursor to potentially amyloidogenic derivatives.

  1992cited by this paper
• Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor.

  1992cited by this paper
• Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

  1991cited by this paper
• Coca chewing and cholera.

  1991cited by this paper
• Mis-sense mutation Val----Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease.

  1991cited by this paper
• A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

  1991cited by this paper
• The 717Val----Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups.

  1991cited by this paper
• Molecular classification of Alzheimer's disease.

  1991cited by this paper
• The molecular pathology of Alzheimer's disease.

  1991cited by this paper
• Mis-sense mutation Val----Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease.

  1991cited by this paper
• Alzheimer's mutation

  1991cited by this paper
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

  1991cited by this paper
• Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells.

  1991cited by this paper
• Cleavage of amyloid beta peptide during constitutive processing of its precursor.

  1990cited by this paper
• Genomic organization of the human-amyloid beta-protein precursor gene.

  1990cited by this paper
• Genomic organization of the human amyloid beta-protein precursor gene.

  1990cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper
• Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch).

  1990cited by this paper
• Hereditary cerebral haemorrhage caused by cortical amyloid angiopathy.

  1988cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related.

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1984cited by this paper

• Single-cell RNA sequencing reveals disease associated changes in brain endothelial cells in the 5XFAD mouse

  2026cites this paper
• Isogenic cortical organoids enable precision targeting of APP variant-specific pathways in Alzheimer’s disease

  2026cites this paper
• Association of work-related noise exposure with cognitive performance: Effect modification by PS-1 rs165932

  2026cites this paper
• Lysosomal protease-mediated APP degradation is pH-dependent, mutation-sensitive, and facilitates tau proteolysis

  2026cites this paper
• Deciphering protein aggregation: Insights into morphology, contributing factors, and molecular pathologies.

  2025cites this paper
• Genetic Correlates of Presenile Dementia and Cognitive Decline in the Armenian Population Following COVID-19: A Case-Control Study

  2025cites this paper
• Contemporary perspectives in cerebral amyloid angiopathy

  2025cites this paper
• Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model

  2025cites this paper
• A Novel APP Knock-In Mouse Model to Study the Protective Effects of the Icelandic Mutation In Vivo

  2025cites this paper
• Alternative splicing in Alzheimer's disease: Mechanisms, therapeutic implications, and 3D modeling approaches

  2025cites this paper
• CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects

  2025cites this paper
• A low frequency damaging SORCS2 variant identified in a family with ADHD compromises receptor stability and quenches activity

  2025cites this paper
• Somatostatin receptor subtypes 1 and 4 regulate neprilysin, the major amyloid-β degrading enzyme in brain

  2025cites this paper
• Sex hormones and diets rich in polyunsaturated ω-6/ω-3 fatty acids modify microbiota distinctly in a mouse model of Alzheimer’s disease

  2025influential citation
• Selective association of EEG microstates with clinical symptoms and mutation status in monogenic Alzheimer disease

  2025cites this paper
• APP β-CTF triggers cell-autonomous synaptic toxicity independent of Aβ

  2025cites this paper
• Modeling Alzheimer’s Disease: A Review of Gene-Modified and Induced Animal Models, Complex Cell Culture Models, and Computational Modeling

  2025cites this paper
• Impairment of Tricarboxylic Acid Cycle (TCA) Cycle in Alzheimer's Disease: Mechanisms, Implications, and Potential Therapies

  2025cites this paper
• Alzheimer’s Disease, β-Amyloid Peptides, and Ubiquitin-Proteasome System: Nutritherapeutic Insights

  2025cites this paper
• Synaptic and synchronic impairments in subcortical brain regions associated with early non-cognitive dysfunction in Alzheimer’s disease

  2025cites this paper
• A Change of Mind: Targeting Amyloid-β with Better Safety Profile.

  2025cites this paper
• Valosin-containing Protein is Cargo in Amyloid Precursor Protein Extracellular Vesicles

  2025cites this paper
• Alternative splicing in aging and aging-related diseases: From pathogenesis to therapy.

  2025cites this paper
• From Plant to Pathway: Molecular Mechanisms of Ruscogenin in Preventing Amyloid-Beta Aggregation through Computational and Experimental Approaches.

  2025cites this paper
• Lysosomal Protease-Mediated APP Degradation is pH-Dependent, Mutation-Sensitive, and Facilitates Tau Proteolysis

  2025cites this paper
• Phenotypic variability in early-onset dementia segregating with a novel APP (p.I718M) variant

  2025cites this paper
• Alzheimer’s disease basics: we all should know

  2025cites this paper
• Design, Ssynthesis, and biological evaluation of β-secretase inhibitors: An integrated study of molecular docking, dynamics, pharmacokinetics, quantum chemistry, and in-vitro analysis for Alzheimer's disease.

  2025cites this paper
• Interactions between daily sleep-wake rhythms, γ-secretase, and amyloid-β peptide pathology point to complex underlying relationships.

  2025cites this paper
• Familial cerebral amyloid disorders with prominent white matter involvement.

  2024cites this paper
• Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease

  2024cites this paper
• Loss of TREM2 diminishes CAA despite an overall increase of amyloid load in Tg‐SwDI mice

  2024cites this paper
• Navigating the Intersection: Diabetes and Alzheimer's Intertwined Relationship.

  2024cites this paper
• A clathrin mediated endocytosis scaffolding protein, Intersectin 1, changes in an isoform, brain region, and sex specific manner in Alzheimer’s disease

  2024cites this paper
• Border-associated macrophages: From physiology to therapeutic targets in Alzheimer's disease.

  2024cites this paper
• Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling

  2024cites this paper
• Novel insights into presenilin 1 mutation associated with a distinctive dementia phenotype and cotton wool plaques

  2024cites this paper
• Biomarkers in Alzheimer’s Disease: Are Olfactory Neuronal Precursors Useful for Antemortem Biomarker Research?

  2024cites this paper
• Amyloid precursor protein induces reactive astrogliosis

  2024cites this paper
• Probable Novel APP Met671Leu Mutation in a Chinese Han Family with Early-Onset Alzheimer’s Disease

  2024cites this paper
• Using Drosophila amyloid toxicity models to study Alzheimer's disease

  2024cites this paper
• Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer’s Disease

  2024cites this paper
• Swedish Alzheimer’s disease variant perturbs activity of retrograde molecular motors and causes widespread derangement of axonal transport pathways

  2024cites this paper
• Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research

  2024cites this paper
• A novel mouse model for N-terminal truncated Aβ2-x generation through meprin β overexpression in astrocytes

  2024cites this paper
• Application of CRISPR/Cas9 System in the Treatment of Alzheimer’s Disease and Neurodegenerative Diseases

  2024cites this paper
• Is the Relationship Between Cardiovascular Disease and Alzheimer’s Disease Genetic? A Scoping Review

  2024cites this paper
• Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion

  2024cites this paper
• A closer look at pathogenic amyloid-β in Alzheimer’s disease using cryo-electron microscopy: a narrative review

  2024cites this paper
• The Amyloid Cascade Hypothesis: A Conclusion in Search of Support.

  2024cites this paper
• Identification of pathological pathways centered on circRNA dysregulation in association with irreversible progression of Alzheimer’s disease

  2024cites this paper
• Pharmacological inhibition of PLK2 kinase activity mitigates cognitive decline but aggravates APP pathology in a sex-dependent manner in APP/PS1 mouse model of Alzheimer's disease

  2024cites this paper
• The pathogenic APP N-terminal Val225Ala mutation alters tau protein liquid-liquid phase separation and exacerbates synaptic damage

  2024cites this paper
• Coptisine reverses Alzheimer’s disease by targeting cholinergic and amyloidogenic pathways

  2024cites this paper
• Plasma membrane repair defect in Alzheimer's disease neurons is driven by the reduced dysferlin expression

  2024cites this paper
• Molecular Therapeutics in Development to Treat Alzheimer’s Disease

  2024cites this paper
• Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease.

  2024cites this paper
• Regulator of G protein signaling 6 mediates exercise-induced recovery of hippocampal neurogenesis, learning, and memory in a mouse model of Alzheimer’s disease

  2024cites this paper
• Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies

  2024cites this paper
• Mercury-mediated neurological diseases: insight into molecular mechanisms, mutant proteins, and structure-based therapeutic inhibitors

  2024cites this paper
• Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer’s disease models

  2024cites this paper
• Recent Therapeutic Gene Editing Applications to Genetic Disorders

  2024cites this paper
• Tau Accumulation Induces Microglial State Alterations in Alzheimer's Disease Model Mice

  2024cites this paper
• Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations

  2024cites this paper
• The dopaminergic system promotes neprilysin-mediated degradation of amyloid-β in the brain

  2024cites this paper
• Suppression of the amyloidogenic metabolism of APP and the accumulation of Aβ by alcadein α in the brain during aging

  2024cites this paper
• Clinical considerations in early-onset cerebral amyloid angiopathy

  2023cites this paper
• BACE-1 Inhibitors Targeting Alzheimer's Disease.

  2023cites this paper
• Comprehensive genetic screening of early-onset dementia patients in an Austrian cohort-suggesting new disease-contributing genes

  2023cites this paper
• Differential effects of familial Alzheimer’s disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity

  2023cites this paper
• Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models

  2023influential citation
• Alternative splicing in neurodegenerative disease and the promise of RNA therapies

  2023cites this paper
• Aβ43 levels determine the onset of pathological amyloid deposition

  2023cites this paper
• RGS6 mediates exercise-induced recovery of hippocampal neurogenesis, learning, and memory in an Alzheimer’s mouse model

  2023cites this paper
• Vector enabled CRISPR gene editing - A revolutionary strategy for targeting the diversity of brain pathologies.

  2023cites this paper
• E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease

  2023cites this paper
• Leveraging Plasma Membrane Repair Therapeutics for Treating Neurodegenerative Diseases

  2023cites this paper
• Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease.

  2023cites this paper
• Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-β in hAβPP Mouse Models Representing the Major Sporadic Alzheimer’s Disease Condition

  2023cites this paper
• Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy

  2023cites this paper
• The Role of Heme and Copper in Alzheimer’s Disease and Type 2 Diabetes Mellitus

  2023cites this paper
• APP in the Neuromuscular Junction for the Development of Sarcopenia and Alzheimer’s Disease

  2023cites this paper
• The structural mechanism of MCIA complex assembly links mitochondrial redox pathways

  2023cites this paper
• Plasma biomarker profiles in autosomal dominant Alzheimer’s disease

  2023cites this paper
• Experimental approaches for altering the expression of Abeta‐degrading enzymes

  2023cites this paper
• Translational potential of synaptic alterations in Alzheimer’s disease patients and amyloid precursor protein knock-in mice

  2023cites this paper
• Moesin is an effector of tau-induced actin overstabilization, cell cycle activation, and neurotoxicity in Alzheimer’s disease

  2023cites this paper
• Deficits in mitochondrial function and glucose metabolism seen in sporadic and familial Alzheimer’s disease derived Astrocytes are ameliorated by increasing hexokinase 1 expression

  2023cites this paper
• Amyloid precursor protein induces reactive astrogliosis

  2023cites this paper
• Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer’s Disease

  2023cites this paper
• Increased glucose metabolism and impaired glutamate transport in human astrocytes are potential early triggers of abnormal extracellular glutamate accumulation in hiPSC‐derived models of Alzheimer's disease

  2023cites this paper
• The assembly of the Mitochondrial Complex I Assembly complex uncovers a redox pathway coordination

  2023cites this paper
• A light at the end of the tunnel – from mutation identification to a potential treatment for Alzheimer’s disease

  2023cites this paper
• Distinct effects of SDC3 and FGFRL1 on selective neurodegeneration in AD and PD

  2023cites this paper
• The effect of EEG and fNIRS in the digital assessment and digital therapy of Alzheimer’s disease: a systematic review

  2023cites this paper
• Effect and Potential Mechanism of Immunotherapy on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-Analysis.

  2023cites this paper
• Mitofusin-2: Functional Switch Between Mitochondrial Function And Neurodegeneration.

  2023cites this paper
• Assessing Drug Administration Techniques in Zebrafish Models of Neurological Disease

  2023cites this paper
• Alzheimer's Disease; Mechanism, Mutations, and Applications of Nano-Medicine.

  2023cites this paper
• An Alternative View of Familial Alzheimer’s Disease Genetics

  2023cites this paper